Much has been learned in the past decade from the study of tissues involved by the disorder
long known as Hodgkin's disease. Two important discoveries have prompted changes in …

Cytokines and hematopoietic growth factors are actively involved in regulation of
proliferation, differentiation, and cellular functions of various cell lineages. Each cytokine …

Acute myeloid leukemias (AMLs) are clinically and molecularly heterogeneous. AML blasts
are clonal cell populations originating from transformed hematopoietic stem cells, and they …

Objective.—To review the role of molecular genetics in the diagnosis of malignant
lymphomas. Data Sources and Study Selection.—Primary research studies and reviews …

Hodgkin lymphoma (HL) accounts for approximately 0.6% of all new cancer cases, 10% of
all lymphomas in the USA, leading to an approximate 9000 new cases per year. It is very …

Hodgkin disease was first described more than 175 years ago. Clinically and
histomorphologically, the features of Hodgkin lymphoma are unusual for a lymphoma or for …

Among all malignancies, hematologic cancers are perhaps the most challenging to manage
in clinical practice due to their relative rarity, broad diversity, and ever-growing complexity …

Historically, the main division of mature lymphoid neoplasms has been between Hodgkin
disease, nowadays called Hodgkin lymphoma (HL), and non‐Hodgkin lymphoma (NHL) …

The field of molecular epidemiology, using modern epidemiological approaches and taking
the advantage of the advances in molecular biology can provide new tools for the …